Otsu, Japan

Hiroyasu Taguchi



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Hiroyasu Taguchi in Imaging Diagnostics

Introduction

Hiroyasu Taguchi is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of imaging agents for neurological diseases. His work focuses on developing innovative solutions to improve diagnostic accuracy and patient outcomes.

Latest Patents

Hiroyasu Taguchi holds a patent for an imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases. This patent discloses a curcumin derivative or a salt thereof, which contains a fluorine atom. The compound is represented by a specific formula that includes various functional groups designed to enhance its diagnostic capabilities. The diagnostic imaging agent is particularly effective for diagnosing diseases associated with amyloid β peptide aggregates, utilizing a compound that exists in both keto and enol forms, each with different affinities to the target aggregates. He has 1 patent in this area.

Career Highlights

Hiroyasu Taguchi is affiliated with Shiga University of Medical Science, where he conducts research and development in medical imaging technologies. His work has been instrumental in advancing the understanding and treatment of neurological diseases through innovative diagnostic methods.

Collaborations

Hiroyasu Taguchi has collaborated with notable colleagues, including Ikuo Tooyama and Shigehiro Morikawa. These collaborations have contributed to the development of his patented technologies and have enhanced the research output at Shiga University of Medical Science.

Conclusion

Hiroyasu Taguchi's contributions to imaging diagnostics represent a significant advancement in the field of medical technology. His innovative approaches and collaborative efforts continue to pave the way for improved diagnostic tools for neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…